[Inhibition of dopamine-induced arterial hypoxemia by haloperidol].
D001163:Arteriovenous Anastomosis / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000097:blood; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D000860:Hypoxia / Q000139:chemically induced*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011652:Pulmonary Circulation / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects
D018492:Dopamine Antagonists; D011955:Receptors, Drug; D002245:Carbon Dioxide; D006220:Haloperidol; D010100:Oxygen; D004298:Dopamine
Hemmung der Dopamin-induzierten arteriellen Hypoxämie durch Haloperidol.